Search Within

Dara Stacy Ross

Formats
  1. Meeting Abstract (86)
  2. Journal Article (57)
  3. Review (4)
  4. Book Section (2)
Groups
  1. Department of Pathology and Laboratory Medicine (149)
  2. GSK Faculty (76)
  3. Solid Tumor Oncology Division (69)
  4. Department of Medicine (68)
  5. Human Oncology and Pathogenesis Program (61)
  6. Breast Medicine Service (55)

More Groups

People
  1. Edi Brogi (69)
  2. Hannah Wen (50)
  3. Fresia Pareja Zea (36)
  4. Marc Ladanyi (36)
  5. Britta Weigelt (34)
  6. Pedram Razavi (33)

More People

Years
  1. 2025 (13)
  2. 2024 (21)
  3. 2023 (11)
  4. 2022 (15)
  5. 2021 (11)
  6. 2020 (17)

More Years

Publications
  1. Laboratory Investigation (40)
  2. Modern Pathology (31)
  3. Journal of Molecular Diagnostics (8)
  4. Journal of Clinical Oncology (6)
  5. Cancer Research (5)
  6. Archives of Pathology & Laboratory Medicine (4)

More Publications

Publishers
  1. Nature Publishing Group (47)
  2. Nature Research (31)
  3. Elsevier Science, Inc. (8)
  4. Oxford University Press (8)
  5. Springer (8)
  6. American Society of Clinical Oncology (6)

More Publishers

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Is there a role for oncotype Dx testing in invasive lobular carcinoma?
    Journal Article

    Conlon, N.; Ross, D. S.; Howard, J.; Catalano, J. P.; Dickler, M. N.; Tan, L. K.
    Breast Journal (2015)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation
    Meeting Abstract

    Li, B. T.; Ross, D. S.; Chaft, J. E.; Hsu, M.; Kako, S.; Aisner, D. L.; Kris, M. G.; Varella-Garcia, M.; Arcila, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
    Journal Article

    Cheng, D. T.; Mitchell, T. N.; Zehir, A.; Shah, R. H.; Benayed, R.; Syed, A.; Chandramohan, R.; Liu, Z. Y.; Won, H. H.; Scott, S. N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • HER2 chromogenic dual in-situ hybridization in cytology cell blocks of breast cancer specimens: Is it better than FISH?
    Meeting Abstract

    Pandya, D.; Oen, H.; Bullock, N.; Rudomina, D.; Serrette, R.; Zheng, T.; Ross, D.; Edelweiss, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • HER2 chromogenic dual in-situ hybridization in cytology cell blocks of breast cancer specimens: Is it better than FISH?
    Meeting Abstract

    Pandya, D.; Oen, H.; Bullock, N.; Rudomina, D.; Serrette, R.; Zheng, T.; Ross, D.; Edelweiss, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Clinicopathological features of breast carcinoma (BC) with PIK3CA mutations
    Meeting Abstract

    Loo, F.; Brogi, E.; Martinez, J.; Bowser, Z.; Flaherty, M.; Ross, D.; Wen, H.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Clinicopathological features of breast carcinoma (BC) with PIK3CA mutations
    Meeting Abstract

    Loo, F.; Brogi, E.; Martinez, J.; Bowser, Z.; Flaherty, M.; Ross, D.; Wen, H.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Optimizing cytology cell blocks for more cellular and reliable immunohistochemical results in breast cancer specimens
    Meeting Abstract

    Bullock, N.; Rudomina, D.; Ross, D.; Rekhtman, N.; Serrette, R.; Cordero, A.; Friedlander, M.; Lin, O.; Edelweiss, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Optimizing cytology cell blocks for more cellular and reliable immunohistochemical results in breast cancer specimens
    Meeting Abstract

    Bullock, N.; Rudomina, D.; Ross, D.; Rekhtman, N.; Serrette, R.; Cordero, A.; Friedlander, M.; Lin, O.; Edelweiss, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save